Kay Ristow

Kay Ristow

UNVERIFIED PROFILE

Are you Kay Ristow?   Register this Author

Register author
Kay Ristow

Kay Ristow

Publications by authors named "Kay Ristow"

Are you Kay Ristow?   Register this Author

42Publications

906Reads

47Profile Views

Bleomycin use in the treatment of Hodgkin lymphoma (HL): toxicity and outcomes in the modern era.

Leuk Lymphoma 2019 Sep 13:1-11. Epub 2019 Sep 13.

Division of Hematology, Mayo Clinic , Rochester , MN , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1663419DOI Listing
September 2019

Clinical Presentation and Diagnostic Challenges of Thyroid Lymphoma: A Cohort Study.

Thyroid 2016 08 6;26(8):1061-7. Epub 2016 Jul 6.

1 Department of Endocrinology, Mayo Clinic , Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/thy.2016.0095DOI Listing
August 2016

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41).

Oncologist 2015 Oct 12;20(10):1149-53. Epub 2015 Aug 12.

Divisions of Hematology and Hematopathology, Mayo Clinic, Rochester, Minnesota USA; Hospital of Bolzano, Department of Hematology & Center of Bone Marrow Transplantation, Bolzano, Italy; Department of Hematology and Oncology, University Hospital Innsbruck, Innsbruck, Austria; University Hospital of Crete, Heraklion, Greece; Athens Medical Center-Psychikon Branch, Athens, Greece; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Hematology Unit, Department of Internal Medicine, Ospedale degli Infermi, Biella, Italy; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy; Hospital Clínic, Hematology, Barcelona, Spain; Cancer Research UK Centre, Southampton, United Kingdom; Dipartimento Biotecnologie Cellulari ed Ematologia, Universitá La Sapienza, Rome, Italy; European Institute of Oncology, Division of Clinical Haemato-Oncology, Milan, Italy; APHP, Saint-Louis Hospital, Hemato-Oncology, and Diderot University-Sorbonne Paris Cité, Paris, France; Département de Pathologie, Groupe Henri Mondor-Albert Chenevier, AP-HP, Creteil, France; Diagnostic Haematopathology, European Institute of Oncology, Milan, Bologna University School of Medicine, Bologna, Italy; St. James's University Hospital, Leeds, United Kingdom; Hospital Clinic, Anatomia Patologica, IDIBAPS, Barcelona, Spain; ICP Locarno, Locarno, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0180DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591947PMC
October 2015

Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphoma.

Clin Cancer Res 2014 Jun 11;20(11):2862-72. Epub 2014 Apr 11.

Authors' Affiliations: Division of Hematology; Division of Epidemiology; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; and Department of Hematology, Tongji Hospital, Tongji University, Shanghai, China

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-2367DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058762PMC
June 2014

Absolute monocyte count at diagnosis and survival in mantle cell lymphoma.

Br J Haematol 2013 Nov 21;163(4):545-7. Epub 2013 Aug 21.

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12531DOI Listing
November 2013

The clinical spectrum of Castleman's disease.

Am J Hematol 2012 Nov 13;87(11):997-1002. Epub 2012 Jul 13.

Division of Hematology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23291DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3900496PMC
November 2012

The absolute monocyte count is associated with overall survival in patients newly diagnosed with follicular lymphoma.

Leuk Lymphoma 2012 Apr 3;53(4):575-80. Epub 2012 Jan 3.

Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109-5948, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.3109/10428194.2011.63
Publisher Site
http://dx.doi.org/10.3109/10428194.2011.637211DOI Listing
April 2012

Patients with celiac disease and B-cell lymphoma have a better prognosis than those with T-cell lymphoma.

Clin Gastroenterol Hepatol 2010 Dec 17;8(12):1042-7. Epub 2010 Sep 17.

Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2010.09.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594736PMC
December 2010

Predicting survival for diffuse large B-cell lymphoma patients using baseline neutrophil/lymphocyte ratio.

Am J Hematol 2010 Nov;85(11):896-9

Division of Hematology/Department of Medicine, Mayo College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.21849DOI Listing
November 2010

Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma.

Am J Hematol 2009 Feb;84(2):93-7

Division of Hematology/Department of Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.21337DOI Listing
February 2009

Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomas.

Br J Haematol 2007 Jun 13;137(5):409-15. Epub 2007 Apr 13.

Division of Hematology/Department Medicine, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2007.06596.xDOI Listing
June 2007

Treatment of benign orbital pseudolymphomas with the monoclonal anti-CD20 antibody rituximab.

Mayo Clin Proc 2007 Jun;82(6):692-9

Department of Internal Medicine, Division of Hematology, College of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
June 2007

The International Prognostic Index predicts outcome after histological transformation of low-grade non-Hodgkin lymphoma.

Leuk Lymphoma 2006 Sep;47(9):1794-9

Divison of Hematology, Department of Internal Medicine, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190600757894DOI Listing
September 2006

Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma.

J Clin Oncol 2005 Oct 26;23(30):7614-20. Epub 2005 Sep 26.

Division of Hematology and Internal Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.02.7243DOI Listing
October 2005

Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders.

J Clin Oncol 2005 Oct 26;23(30):7574-82. Epub 2005 Sep 26.

Division of Hematology, Department of Internal Medicine, Mayo Clinic and Mayo Foundation, 200 First St, SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2005.01.0934
Publisher Site
http://dx.doi.org/10.1200/JCO.2005.01.0934DOI Listing
October 2005

Clinical outcome of patients with subcutaneous panniculitis-like T-cell lymphoma.

Leuk Lymphoma 2005 May;46(5):703-8

Division of Hematology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190500051380DOI Listing
May 2005

Prognostic factors in patients with post-transplant lymphoproliferative disorders (PTLD) in the rituximab era.

Leuk Lymphoma 2005 Feb;46(2):191-6

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190400012011DOI Listing
February 2005

Subsequent chemotherapy regimens are well tolerated after radioimmunotherapy with yttrium-90 ibritumomab tiuxetan for non-Hodgkin's lymphoma.

J Clin Oncol 2002 Sep;20(18):3885-90

Divisions of Hematology and Nuclear Medicine, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2002.10.143DOI Listing
September 2002